Roshni R. Singaraja

• Ass. Professor at the Yong Loo Lin Sch of Medicine, Singapore

Roshni R. Singaraja is a distinguished researcher with over two decades of expertise in cardiovascular, neurodegenerative, and metabolic disorders. Her work has substantially advanced the understanding of the genetic and molecular mechanisms underlying conditions such as atherosclerosis, diabetes, and NAFLD. She has identified and validated key therapeutic targets, including CYP8B1 and ABCA1, elucidating their roles in enhancing insulin sensitivity, mitigating atherosclerosis, and offering potential avenues for therapeutic intervention. Her methodological expertise encompasses human genetics, mouse models, and cutting-edge techniques. Through extensive collaborations with industry and academic partners, she has made sustained contributions to the cardiovascular research field, reflected by an H-index of 49. Dedicated to mentorship and capacity building, she actively trains students and postdoctoral researchers while translating scientific insights into innovative strategies for the prevention and treatment of prevalent cardiometabolic and neurodegenerative diseases.